News & Updates
Filter by Specialty:
GLP-1RA users face no elevated risk of pancreatic cancer
16 Jan 2024
byJairia Dela Cruz
Among individuals with type 2 diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) does not contribute to increased pancreatic cancer risk, according to a study.
GLP-1RA users face no elevated risk of pancreatic cancer
16 Jan 2024Voice-based AI makes insulin management a breeze for T2D patients
13 Jan 2024
byJairia Dela Cruz
A voice-based conversational artificial intelligence application helps type 2 diabetes (T2D) patients navigate basal insulin titration at home and, in turn, achieve rapid glycaemic control, as reported in a study.
Voice-based AI makes insulin management a breeze for T2D patients
13 Jan 2024Semaglutide trims down weight in patients with severe obesity
12 Jan 2024
byStephen Padilla
Use of semaglutide 2.4 mg results in substantial weight reduction in patients with severe obesity who had previously undergone bariatric surgery (BS) but failed to achieve satisfactory weight loss, reports a recent study.